Barrett's esophagus

Journal of Gastroenterology

Volumn 37, Issue 9, 2002, Pages 685-690

  Terano, Akira ^a   Morita, Katsuo ^a   Nakamura, Tetsuya ^a   Ohkura, Yasuo ^a   Ono, Yuko ^a   Fujimori, Takahiro ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Adenocarcinoma; Barrett's esophagus; Dysplasia

Indexed keywords

CYCLIN D1; GROWTH FACTOR; ONCOPROTEIN; PROTEIN P16; PROTEIN P53;

ARGON PLASMA COAGULATION; BARRETT ESOPHAGUS; CARCINOGENESIS; COLUMNAR EPITHELIUM; DISEASE CLASSIFICATION; ENDOSCOPIC SURGERY; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; ESOPHAGUS SURGERY; GASTROESOPHAGEAL REFLUX; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE BIOPSY; INTESTINE METAPLASIA; LOW LEVEL LASER THERAPY; LOWER ESOPHAGUS SPHINCTER; ONCOGENE H RAS; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE;

BARRETT ESOPHAGUS; GASTROESOPHAGEAL REFLUX; HUMANS;

EID: 0036709388     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350200112     Document Type: Review

References (37)

1. Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS. Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 2000;119:333-8.
2. Barrett NR. Chronic peptic ulcer of the oesophagus oesophagitis. Br J Surg 1950;38:175-82.
3. Allison PR, Johnstone AS. The oesophagus lined with gastric mucous membrane. Thorax 1953;8:87-101.
4. Spechler SJ. Clinical practice: Barrett's esophagus. N Engl J Med 2002;346:836-42.
5. Sampliner RE. Practice guidelines on the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 1998;93: 1028-31.
6. Spechler SJ, Zeroogian JM, Antonioli DA, Wang HH, Goyal RK. Prevalence of metaplasia at the gastro-esophageal junction. Lancet 1994;344:1533-6.
7. Sharma P, Morales TG, Sampliner RE. Short segment Barrett's esophagus-the need for standardization of the definition and of endoscopic criteria. Am J Gastroenterol 1998;93:1033-6.
8. Hoshihara Y, Kogure T. Endoscopic diagnosis of Barrett's epithelium (in Japanese with English abstract). Shoukaki Naishikyou (Endoscopia Digestiva) 1997;9:897-901.
9. Levine DS, Rubin CE, Reid BJ, Haggitt RC. Specialized metaplastic columnar epithelium in Barrett's esophagus: A comparative transmission electron microscopic study. Lab Invest 1989;60:418-32.
10. Paull A, Trier JS, Dalton MD, Camp RC, Loeb P, Goyal RK. The histologic spectrum of Barrett's esophagus. N Engl J Med 1976;295:476-80.
11. Spechler SJ, Goyal RK. Barrett's esophagus. N Engl J Med 1986;315:362-71.
12. Mossberg SM. The columnar-lined esophagus (Barrett syndrome)-an acquired condition? Gastroenterology. 1966;50:671-6.
13. Qualman SJ, Murray RD, McClung HJ, Lucas J. Intestinal metaplasia is age-related in Barrett's esophagus. Arch Pathol Lab Med 1990;114:1236-40.
14. Lapertosa G, Baracchini P, Fulcheri E. Mucin histochemical analysis in the interpretation of Barrett's esophagus. Results of a multicenter study. The Operative Group for the Study of Esophageal Precancer. Am J Clin Pathol 1992;98;61-6.
15. Lee RG. Mucins in Barrett's esophagus: a histochemical study. Am J Clin Pathol 1984;81:500-3.
16. Griffin M, Sweeney EC. The relationship of endocrine cells, dysplasia and carcinoembryonic antigen in Barrett's mucosa to adenocarcinoma of the oesophagus. Histopathology 1987;11:53-62.
17. Takubo K, Sasajima K, Yamashita K, Tanaka Y, Fujita K. Double muscularis mucosae in Barrett's esophagus. Hum Pathol 1991;22:1158-61.
18. Rubio CA, Riddell R. Musculo-fibrous anomaly in Barrett's mucosa with dysplasia. Am J Surg Pathol 1988;12:885-9.
19. Chejfec G. Atypias, dysplasias, and neoplasias of the esophagus and stomach. Semin Diagn Pathol 1985;2:31-41.
20. Karl TR, Pindyck F, Sicular A. Zollinger-Ellison syndrome with esophagitis and Barrett mucosa. Am J Gastroenterol 1983;78: 611-4.
21. Robertson CS, Mayberry JF, Nicholson DA, James PD, Atkinson M. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus. Br J Surg 1988;75:760-3.
22. Morson BC. Barrett's esophagus. In: Morson & Dawson's gastrointestinal pathology. 3rd ed. Oxford: Blackwell Scientific; 1990. p. 47-9.
23. Robertson CS, Mayberry JF, Nicholson DA, James PD, Atkinson M. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus. Br J Surg 1988;75:760-3.
24. Hameeteman W, Tytgat GN, Houthoff HJ, van den Tweel JG. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989;96:1249-956.
25. Paull A, Trier JS, Dalton MD, Camp RC, Loeb P, Goyal RK. The histologic spectrum of Barrett's esophagus. N Engl J Med 1976;295:476-80.
26. Kabashima A, Yao T, Sugimachi K, Tsuneyoshi M. Relationship between biologic behavior and phenotypic expression in intramucosal gastric carcinomas. Hum Pathol 2002;33:80-6.
27. Reid BJ, Haggitt RC, Rubin CE, Roth G, Surawicz CM, Van Belle G, et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol 1988;19:166-78.
28. Jankowski JA, Wright NA, Meltzer SJ, Triadafilopoulos G, Geboes K, Casson AG, et al. Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Pathol 1999;154:965-73.
29. Casson AG, Manolopoulos B, Troster M, Kerkvliet N, O'Malley F, Inculet R, et al. Clinical implications of p53 gene mutation in the progression of Barrett's epithelium to invasive esophageal cancer. Am J Surg 1994;167:52-7.
30. Barrett MT, Sanchez CA, Galipeau PC, Neshat K, Emond M, Reid B.J. Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus. Oncogene 1996;13:1867-73.
31. Sorsdahl K, Casson AG, Troster M, Van Meyel D, Inculet R, Chambers AF. p53 and ras gene expression in human esophageal cancer and Barrett's epithelium: a prospective study. Cancer Detect Prev 1994;18:179-85.
32. Jiang W, Zhang YJ, Kahn SM, Hollstein MC, Santella RM, Lu SH, et al. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc Natl Acad Sci U S A 1993;90:9026-30.
33. Hardwick RH, Shepherd NA, Moorghen M, Newcomb PV, Alderson D. c-erbB-2 overexpression in the dysplasia/carcinoma sequence of Barrett's oesophagus. J Clin Pathol 1995;48:129-32.
34. Jankowski J, Hopwood D, Wormsley KG. Flow-cytometric analysis of growth-regulatory peptides and their receptors in Barrett's oesophagus and oesophageal adenocarcinoma. Scand J Gastroenterol 1992;27:147-54.
35. Bailey T, Biddlestone L, Shepherd N, Barr H, Warner P, Jankowski J. Altered cadherin and catenin complexes in the Barrett's esophagus-dysplasia-adenocarcinoma sequence: correlation with disease progression and dedifferentiation. Am J Pathol 1998;152:135-44.
36. Singh SP, Lipman J, Goldman H, Ellis FH Jr, Aizenman L, Cangi MG, et al. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma. Cancer Res 1998;58:1730-5.
37. Bergein FO, Masoud P, John MH. Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointest Endosc 1999;49:1-7.